CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

76 hedge funds and large institutions have $155M invested in Cascadian Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$123K
Puts
$65K
Net Calls
Net Calls Change

Top Buyers

1 +$5.2M
2 +$1.67M
3 +$1.42M
4
Boston Partners
Boston Partners
Massachusetts
+$1.41M
5
State Street
State Street
Massachusetts
+$1.4M

Top Sellers

1 -$4.61M
2 -$3.31M
3 -$1.56M
4
Millennium Management
Millennium Management
New York
-$1.42M
5
RG
Redmile Group
California
-$1.25M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$347K
27
$312K
28
$262K
29
$259K
30
$252K
31
$231K
32
$226K
33
$225K
34
$216K
35
$194K
36
$170K
37
$143K
38
$143K
39
$142K
40
$136K
41
$104K
42
$103K
43
$82K
44
$79K
45
$75K
46
$72K
47
$71K
48
$63K
49
$52K
50
$48K